(2 years, 5 months ago)
Commons ChamberAs I have said before, no country got every decision right during the pandemic, but one thing we did get right was our response in terms of diagnostics, vaccinations and antivirals. That combination allowed us to become the first country in Europe to open up and therefore also to boost our economy. I will make sure that the hon. Gentleman gets the meeting he has asked for.
(2 years, 11 months ago)
Commons ChamberIf my right hon. Friend will allow me, I am about to come to precisely the point he raises.
The second thing about omicron that I want to share is that, although we do not yet have a complete picture of its severity, even if its severity is significantly lower, the much higher transmissibility of omicron means that it still has the potential to overwhelm the NHS. Let us take the current observed doubling time of two years—[Interruption.] Sorry. Let us take the current doubling time of two days. If, for argument’s sake, omicron is only half as severe as delta, after the lag between cases and hospitalisations has taken effect, that would buy us only two days before omicron hospitalisations reach the same level as for delta.
I will do so later.
In England, 10 people are confirmed to have been hospitalised with the omicron variant. I know that some hon. Members have said that, because confirmed hospitalisations from omicron are low, we do not need to act, but it is the fact that omicron hospitalisations are low that means now is the best time to act. We have seen during previous waves—we have already seen this—that the lag between infections and hospitalisations is about two weeks. When infections are rising so quickly, we are likely to see a substantial rise in hospitalisations before any measure starts to have an impact, so there really is no time to lose.
The point about managed quarantine and those people who are already in it is important. I am told that the practice in the past was to require them to complete their quarantine period, but I understand the importance of the point. I have asked for urgent advice about what that means. I hope to add to that very soon.
One of the things we know about omicron is the significant genetic mutations and changes that have happened to the spike protein. This morning, at the Science and Technology Committee, Kate Bingham, the Government’s vaccine tsar, said that the Government’s decision to pull the plug on the Valneva contract was mistaken. Will the Secretary of State make a commitment today to revisit that, given the specific technologies that exist with a whole-virus vaccine, which Ms Bingham described as “having the edge” over other vaccines, and which would help the distribution of vaccines to the rest of the world?
I think the hon. Gentleman will understand that when the Government make decisions on vaccines they take expert advice, most of which comes from the JCVI. We always listen carefully to that advice to make a final decision, but it is coming on a number of occasions and is constantly kept under review.
(3 years ago)
Commons ChamberThe emergence of omicron is not really much of a surprise; it is more a case of when, not if. Anecdotal evidence from South Africa suggests that, while it may be more infectious, the potency seems to be more limited. Of particular concern are the mutations to the spike protein in two specific areas, so what action are the Government taking to put in additional resources to adjuvant therapy development, especially given the impact on monoclonal antibody therapies and the vaccine, and what is the status of genomic surveillance in the UK at present?
First, I think it is fair to say that our genomics surveillance has never been so strong. It was getting stronger even before the pandemic, but because of the pandemic, there has been a huge amount of investment, and it has paid off UK-wide. On the treatments, there is some concern about this new variant and Ronapreve, which is one of the key monoclonal antibodies that we use for treatment, but it is just concern at this point; there is no particular evidence. However, part of the reason for taking these measures is to buy the time we need—two to three weeks—to give our scientists time to assess the risk of this variant properly.
(3 years, 5 months ago)
Commons ChamberYes, I do agree. The vaccine programme is our wall of protection, and every jab builds that wall higher. As immunity wears off, we need to make sure that people get a booster with a third jab. As we have announced, the boosting programme will begin with the most vulnerable cohorts in September.
I thank you, Mr Speaker, for your indulgence in allowing me to acknowledge the passing from covid last night of Father Stan Swamy, a humanitarian Jesuit priest who had been held in custody in India since October last year. I hope the House will join me in expressing our condolences to all who knew him.
On today’s statement, there is a fundamental weakness in the Secretary of State’s comments. The covid virus did not get the memo and has not read his statement. Vaccines are really important, but if he wants to build a ring of defence around the continued spread of the virus, he will find that surveillance is absolutely key. Last week, I was promised evidence from Porton Down supporting the continued use of Innova lateral flow devices across the country, but that information has not been passed to me. I also asked for the MHRA’s letter recommending the extension of the exceptional usage authorisation, but, again, that has not been forthcoming. When can I expect to receive this important information?
First, may I associate myself with the hon. Gentleman’s expression of condolences? On his substantive question, I am not fully aware of the information he has requested, but I have noted it and will look into it and write to him.
(3 years, 5 months ago)
Commons ChamberYes, I can give my hon. Friend that assurance. The backlog is already at 5 million, and as I have said today, it is unfortunately going to get a lot worse before it gets better. I think we can all understand why, but today’s announcement will certainly have helped in our march to clear the backlog. My hon. Friend will know that the Government have given significant additional funding, in the billions, to help with that, but there will be a lot more to come in dealing with the priorities, especially cancer.
All the warm words from the Secretary of State towards the NHS at the top of his statement were completely demolished by his attitude towards a breast cancer surgeon when he said that she should know better. The reality is that she does know better, and he should apologise to the hon. Member for Central Ayrshire (Dr Whitford) for those absolutely outrageous comments. And to use the escalation of cases in Scotland as a political tool is absolutely disgraceful. I want to talk about the—